{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:22:15Z","timestamp":1789672935580,"version":"4.0.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,26]]},"DOI":"10.7759\/cureus.53017","type":"journal-article","created":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T05:40:51Z","timestamp":1706334051000},"source":"Crossref","is-referenced-by-count":4,"title":["Evaluating the Diagnostic Potential of Serum Vascular Endothelial Growth Factor and Adiponectin in Diabetic Peripheral Neuropathy"],"prefix":"10.7759","author":[{"given":"Palani Selvam","family":"Mohanraj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arani","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniruddha","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Ranjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinoth","family":"Rajendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupriya","family":"Velu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U","family":"Venkatesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-019-1212-8","article-title":"Epidemiology of peripheral neuropathy and lower extremity disease in diabetes","volume":"19","author":"Hicks CW","year":"2019","unstructured":"Hicks CW, Selvin E. Epidemiology of peripheral neuropathy and lower extremity disease in diabetes. Curr Diab Rep. 2019, 19:86. 10.1007\/s11892-019-1212-8","journal-title":"Curr Diab Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5378439","article-title":"Diabetic neuropathy: new insights to early diagnosis and treatments","volume":"2018","author":"Yorek M","year":"2018","unstructured":"Yorek M, Malik RA, Calcutt NA, Vinik A, Yagihashi S. Diabetic neuropathy: new insights to early diagnosis and treatments. J Diabetes Res. 2018, 2018:5378439. 10.1155\/2018\/5378439","journal-title":"J Diabetes Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9524635","article-title":"Understanding diabetic neuropathy: focus on oxidative stress","volume":"2020","author":"Pang L","year":"2020","unstructured":"Pang L, Lian X, Liu H, et al.. Understanding diabetic neuropathy: focus on oxidative stress. Oxid Med Cell Longev. 2020, 2020:9524635. 10.1155\/2020\/9524635","journal-title":"Oxid Med Cell Longev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.7898.1","article-title":"Updates in diabetic peripheral neuropathy","volume":"5","author":"Juster-Switlyk K","year":"2016","unstructured":"Juster-Switlyk K, Smith AG. Updates in diabetic peripheral neuropathy. F1000Res. 2016, 5:10.12688\/f1000research.7898.1","journal-title":"F1000Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s1388-2457(03)00025-7","article-title":"Diabetic neuropathy: a review emphasizing diagnostic methods","volume":"114","author":"Perkins BA","year":"2003","unstructured":"Perkins BA, Bril V. Diabetic neuropathy: a review emphasizing diagnostic methods. Clin Neurophysiol. 2003, 114:1167-75. 10.1016\/s1388-2457(03)00025-7","journal-title":"Clin Neurophysiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2009.02680.x","article-title":"Serum VEGF increases in diabetic polyneuropathy, particularly in the neurologically active symptomatic stage","volume":"26","author":"Deguchi T","year":"2009","unstructured":"Deguchi T, Hashiguchi T, Horinouchi S, et al.. Serum VEGF increases in diabetic polyneuropathy, particularly in the neurologically active symptomatic stage. Diabet Med. 2009, 26:247-52. 10.1111\/j.1464-5491.2009.02680.x","journal-title":"Diabet Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1797.2009.01085.x","article-title":"Role of the VEGF 936 C\/T polymorphism in diabetic microvascular complications in type 2 diabetic patients","volume":"14","author":"Kim HW","year":"2009","unstructured":"Kim HW, Ko GJ, Kang YS, Lee MH, Song HK, Kim HK, Cha DR. Role of the VEGF 936 C\/T polymorphism in diabetic microvascular complications in type 2 diabetic patients. Nephrology (Carlton). 2009, 14:681-8. 10.1111\/j.1440-1797.2009.01085.x","journal-title":"Nephrology (Carlton)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1210\/er.2005-0005","article-title":"Adiponectin and adiponectin receptors","volume":"26","author":"Kadowaki T","year":"2005","unstructured":"Kadowaki T, Yamauchi T. Adiponectin and adiponectin receptors. Endocr Rev. 2005, 26:439-51. 10.1210\/er.2005-0005","journal-title":"Endocr Rev"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/BF00400697","article-title":"A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population","volume":"36","author":"Young MJ","year":"1993","unstructured":"Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993, 36:150-4. 10.1007\/BF00400697","journal-title":"Diabetologia"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.23.6.750","article-title":"Diabetic neuropathy examination: a hierarchical scoring system to diagnose distal polyneuropathy in diabetes","volume":"23","author":"Meijer JW","year":"2000","unstructured":"Meijer JW, van Sonderen E, Blaauwwiekel EE, Smit AJ, Groothoff JW, Eisma WH, Links TP. Diabetic neuropathy examination: a hierarchical scoring system to diagnose distal polyneuropathy in diabetes. Diabetes Care. 2000, 23:750-3. 10.2337\/diacare.23.6.750","journal-title":"Diabetes Care"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.3.697","article-title":"Clinical diagnosis of diabetic polyneuropathy with the diabetic neuropathy symptom and diabetic neuropathy examination scores","volume":"26","author":"Meijer JW","year":"2003","unstructured":"Meijer JW, Bosma E, Lefrandt JD, et al.. Clinical diagnosis of diabetic polyneuropathy with the diabetic neuropathy symptom and diabetic neuropathy examination scores. Diabetes Care. 2003, 26:697-701. 10.2337\/diacare.26.3.697","journal-title":"Diabetes Care"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19010275","article-title":"VEGF signaling in neurological disorders","volume":"19","author":"Shim JW","year":"2018","unstructured":"Shim JW, Madsen JR. VEGF signaling in neurological disorders. Int J Mol Sci. 2018, 19:275. 10.3390\/ijms19010275","journal-title":"Int J Mol Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2015.06.008","article-title":"Association of adiponectin gene polymorphisms with an elevated risk of diabetic peripheral neuropathy in type 2 diabetes patients","volume":"29","author":"Ji ZY","year":"2015","unstructured":"Ji ZY, Li HF, Lei Y, et al.. Association of adiponectin gene polymorphisms with an elevated risk of diabetic peripheral neuropathy in type 2 diabetes patients. J Diabetes Complications. 2015, 29:887-92. 10.1016\/j.jdiacomp.2015.06.008","journal-title":"J Diabetes Complications"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2337\/db09-1338","article-title":"Macrophage adiponectin expression improves insulin sensitivity and protects against inflammation and atherosclerosis","volume":"59","author":"Luo N","year":"2010","unstructured":"Luo N, Liu J, Chung BH, Yang Q, Klein RL, Garvey WT, Fu Y. Macrophage adiponectin expression improves insulin sensitivity and protects against inflammation and atherosclerosis. Diabetes. 2010, 59:791-9. 10.2337\/db09-1338","journal-title":"Diabetes"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/ncpcardio1398","article-title":"Protective vascular and myocardial effects of adiponectin","volume":"6","author":"Goldstein BJ","year":"2009","unstructured":"Goldstein BJ, Scalia RG, Ma XL. Protective vascular and myocardial effects of adiponectin. Nat Clin Pract Cardiovasc Med. 2009, 6:27-35. 10.1038\/ncpcardio1398","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.567959","article-title":"Serum adiponectin levels are positively associated with diabetic peripheral neuropathy in Chinese patients with type 2 diabetes","volume":"11","author":"Sun Q","year":"2020","unstructured":"Sun Q, Yan B, Yang D, et al.. Serum adiponectin levels are positively associated with diabetic peripheral neuropathy in Chinese patients with type 2 diabetes. Front Endocrinol (Lausanne). 2020, 11:567959. 10.3389\/fendo.2020.567959","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinbiochem.2014.10.009","article-title":"Association of serum adiponectin with diabetic microvascular complications among south Indian type 2 diabetic subjects - (CURES-133)","volume":"48","author":"Pradeepa R","year":"2015","unstructured":"Pradeepa R, Surendar J, Indulekha K, Chella S, Anjana RM, Mohan V. Association of serum adiponectin with diabetic microvascular complications among south Indian type 2 diabetic subjects - (CURES-133). Clin Biochem. 2015, 48:33-8. 10.1016\/j.clinbiochem.2014.10.009","journal-title":"Clin Biochem"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-2259","article-title":"Proinflammatory cytokines predict the incidence and progression of distal sensorimotor polyneuropathy: KORA F4\/FF4 study","volume":"40","author":"Herder C","year":"2017","unstructured":"Herder C, Kannenberg JM, Huth C, et al.. Proinflammatory cytokines predict the incidence and progression of distal sensorimotor polyneuropathy: KORA F4\/FF4 study. Diabetes Care. 2017, 40:569-76. 10.2337\/dc16-2259","journal-title":"Diabetes Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/226469-evaluating-the-diagnostic-potential-of-serum-vascular-endothelial-growth-factor-and-adiponectin-in-diabetic-peripheral-neuropathy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:14:43Z","timestamp":1707509683000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/226469-evaluating-the-diagnostic-potential-of-serum-vascular-endothelial-growth-factor-and-adiponectin-in-diabetic-peripheral-neuropathy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,26]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.53017","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,26]]}}}